The ASAM Review Course in Addiction Medicine

The ASAM Review Course 2017

ASAM Review Course

Hotel                 Register Now

Business session

The ASAM Review Course in Addiction Medicine is widely recognized as the essential primer for physicians and other healthcare professionals who are preparing for a career in addiction medicine, as well as for primary care providers who wish to increase their skills in identifying and managing patients whose medical problems are caused or exacerbated by substance use disorders.

The course offers two and a half days of sessions which are mapped to the addiction medicine exam blueprint of topics for the exam and features an outstanding faculty. Approximately 600-800 professional attend this popular course each time it is offered. ASAM’s Review Course has had a major impact on advancing a common base of scientific knowledge among physicians and other healthcare professionals.

Learning Objectives

Upon completion, participants should be able to:

  • Demonstrate practical knowledge on the neurobiology of addiction and articulate its activity in terms useful in a clinical setting
  • Describe the effects of alcohol, tobacco and other drugs in both tolerant and non-tolerant individuals
  • Describe the process for diagnosing addiction and differentiating the symptoms of addiction from those of other medical or psychiatric disorders
  • Explain the various pharmacologic and psychosocial treatments for addictive disorders and describe the factors that should be considered in selecting a treatment modality to match the needs of a specific patient
  • Describe the precipitants of relapse and current evidence-based practices to prevent and manage relapse
 

The Certification Exam

Starting in the fall of 2017, ABPM will offer physicians who are certified by a Member Board of the American Board of Medical Specialties (ABMS) the opportunity to become certified in the subspecialty of addiction medicine. .

The next five years following the date of the first exam is an optimum time for physicians to become Board Certified in addiction medicine. Physicians who are already certified by any of the 24 member Boards and have substantial experience in the field of addiction medicine are eligible to apply to take the examination.  During the first five years the examination is given, individuals will NOT be required to complete an addiction medicine fellowship. After that, a one-year addiction medicine fellowship will be required.

For more information, please visit http://www.theabpm.org/.

Who Should Attend

The ASAM Review Course in Addiction Medicine provides an up-to-date review of the core content of addiction medicine for:

  • Physicians preparing for the ABPM Board Certification/Recertification Examination in addiction medicine
  • Addiction specialists seeking a "refresher" course that incorporates recent developments in addiction science and practice
  • Non-specialist physicians and other healthcare professionals needing the knowledge to identify and manage problems related to substance use disorders for their patients 

 

gaylord hotel

Join Us In Dallas (Grapevine), TX

The ASAM Review Course hotel is The Gaylord Texan Resort set on Lake Grapevine. It offers a first-class experience with southern hospitality featuring an atrium with 4.5 acres of lush gardens, numerous restaurants and eclectic shops. This hotel is located six miles from the Dallas/Fort Worth Airport (DFW) and only two and a half miles from the Grapevine Mills Mall.

Pre-Course Offerings - Wednesday, July 26, 2017

BUP-Horizontal-Logo 

The ASAM Buprenorphine Waiver Course - LIVE

1:00 pm - 5:30 pm

(LIVE Webinar stream available)

Additional Fees Apply

The ASAM Buprenorphine Course will ensure that participants are exposed to the highest quality, evidence-based practices when using buprenorphine to treat opioid use disorders.

Read More

 

CORE-Banner-283x55 

The CO*RE/ASAM Opioid Prescribing Course - LIVE

6:30 pm - 9:00 pm

(LIVE Webinar stream available)

FREE

Review safe prescribing habits and examine the difference between extended release/long acting medications to help ensure patient safety and effective pain management.

Read More